Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1

Molecular and Cellular Neuroscience

Volumn 57, Issue , 2013, Pages 73-82

  Liu, Han ^a,b   Liu, Jianuo ^b   Liang, Shangdong ^a   Xiong, Huangui ^b  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cortical neurons; HIV 1gp120; Kv channels; Neuronal injury; Neuroprotection; Plasma gelsolin

Indexed keywords

GELSOLIN; GLYCOPROTEIN GP 120; SHAB POTASSIUM CHANNEL; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL KV2.1;

ANIMAL CELL; ARTICLE; BRAIN CELL CULTURE; CELL VIABILITY; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; FETUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MEMBRANE POTENTIAL; NERVE CELL CULTURE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPRAGUE DAWLEY RAT; STEADY STATE; UPREGULATION; WESTERN BLOTTING;

ACTION POTENTIALS; ANIMALS; APOPTOSIS; CELLS, CULTURED; CEREBRAL CORTEX; GELSOLIN; HIV ENVELOPE PROTEIN GP120; NEURONS; NEUROPROTECTIVE AGENTS; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SHAB POTASSIUM CHANNELS;

EID: 84887218173     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2013.10.008     Document Type: Article

References (66)

1. Anderson E., Zink W., Xiong H., Gendelman H.E. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 2002, 31(Suppl. 2):S43-S54.
2. Azuma T., Koths K., Flanagan L., Kwiatkowski D. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J. Biol. Chem. 2000, 275:3761-3766.
3. Bucki R., Levental I., Kulakowska A., Janmey P.A. Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr. Protein Pept. Sci. 2008, 9:541-551.
4. Carro E. Gelsolin as therapeutic target in Alzheimer's disease. Expert Opin. Ther. Targets 2010, 14:585-592.
5. Catani M.V., Corasaniti M.T., Navarra M., Nistico G., Finazzi-Agro A., Melino G. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J. Neurochem. 2000, 74:2373-2379.
6. + currents. PloS one 2011, 6:e25994.
7. Endres M., Fink K., Zhu J., Stagliano N.E., Bondada V., Geddes J.W., Azuma T., Mattson M.P., Kwiatkowski D.J., Moskowitz M.A. Neuroprotective effects of gelsolin during murine stroke. J. Clin. Invest. 1999, 103:347-354.
8. Furukawa K., Fu W., Li Y., Witke W., Kwiatkowski D.J., Mattson M.P. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 1997, 17:8178-8186.
9. Garcia-Exposito L., Ziglio S., Barroso-Gonzalez J., de Armas-Rillo L., Valera M.S., Zipeto D., Machado J.D., Valenzuela-Fernandez A. Gelsolin activity controls efficient early HIV-1 infection. Retrovirology 2013, 10:39.
10. Gelman B.B., Soukup V.M., Schuenke K.W., Keherly M.J., Holzer C., Richey F.J., Lahart C.J. Acquired neuronal channelopathies in HIV-associated dementia. J. Neuroimmunol. 2004, 157:111-119.
11. Gendelman H.E., Eiden L., Epstein L., Grant I., Lipton S., McArthur J., Pomerantz R., Price R., Swindells S. The neuropathogenesis of HIV-1-dementia: a panel discussion. The Neurology of AIDS 1998, 1-10. Chapman and Hall, New York. 1st ed. H.E. Gendelman, S.A. Lipton, L.G. Epstein, S. Swindells (Eds.).
12. Goncalves A.F., Dias N.G., Moransard M., Correia R., Pereira J.A., Witke W., Suter U., Relvas J.B. Gelsolin is required for macrophage recruitment during remyelination of the peripheral nervous system. Glia 2010, 58:706-715.
13. Harms C., Bosel J., Lautenschlager M., Harms U., Braun J.S., Hortnagl H., Dirnagl U., Kwiatkowski D.J., Fink K., Endres M. Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Mol. Cell. Neurosci. 2004, 25:69-82.
14. Haverland N., Pottiez G., Wiederin J., Ciborowski P. Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation. J. Transl. Med. 2010, 8:137.
15. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 2010, 75:2087-2096.
16. Herrington J. Gating modifier peptides as probes of pancreatic beta-cell physiology. Toxicon 2007, 49:231-238.
17. Hu C.L., Zeng X.M., Zhou M.H., Shi Y.T., Cao H., Mei Y.A. Kv 1.1 is associated with neuronal apoptosis and modulated by protein kinase C in the rat cerebellar granule cell. J. Neurochem. 2008, 106:1125-1137.
18. + current by human monocyte-derived macrophages. Glia 2009, 57:1492-1500.
19. Jagadish T., Pottiez G., Fox H.S., Ciborowski P. Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques. J. Neurovirol. 2012, 18:113-119.
20. Kaul M., Lipton S.A. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J. NeuroImmune Pharmacol. 2006, 1:138-151.
21. Kaul M., Lipton S.A. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 2006, 4:307-318.
22. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
23. Keblesh J., Hu D., Xiong H. Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders. J. NeuroImmune Pharmacol. 2009, 4:60-70.
24. Keblesh J.P., Dou H., Gendelman H.E., Xiong H. 4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis. J. NeuroImmune Pharmacol. 2009, 4:317-327.
25. Kranick S.M., Nath A. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (Minneap Minn) 2012, 18:1319-1337.
26. Kulakowska A., Drozdowski W., Sadzynski A., Bucki R., Janmey P.A. Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders. Eur. J. Neurol. 2008, 15:584-588.
27. Kulakowska A., Ciccarelli N.J., Wen Q., Mroczko B., Drozdowski W., Szmitkowski M., Janmey P.A., Bucki R. Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol. 2010, 10:107.
28. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 1999, 11:103-108.
29. Kwiatkowski D.J., Stossel T.P., Orkin S.H., Mole J.E., Colten H.R., Yin H.L. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986, 323:455-458.
30. Kwiatkowski D.J., Westbrook C.A., Bruns G.A., Morton C.C. Localization of gelsolin proximal to ABL on chromosome 9. Am. J. Hum. Genet. 1988, 42:565-572.
31. Le H.T., Hirko A.C., Thinschmidt J.S., Grant M., Li Z., Peris J., King M.A., Hughes J.A., Song S. The protective effects of plasma gelsolin on stroke outcome in rats. Exp. Transl. Stroke Med. 2011, 3:13.
32. Lee S., Milescu M., Jung H.H., Lee J.Y., Bae C.H., Lee C.W., Kim H.H., Swartz K.J., Kim J.I. Solution structure of GxTX-1E, a high-affinity tarantula toxin interacting with voltage sensors in Kv2.1 potassium channels. Biochemistry 2010, 49:5134-5142.
33. Lei Z., Deng P., Li Y., Xu Z.C. Downregulation of Kv4.2 channels mediated by NR2B-containing NMDA receptors in cultured hippocampal neurons. Neuroscience 2010, 165:350-362.
34. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1995, 332:934-940.
35. Louboutin J.P., Agrawal L., Reyes B.A., van Bockstaele E.J., Strayer D.S. Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases. Neuroscience 2012, 214:68-77.
36. Mattson M.P., Haughey N.J., Nath A. Cell death in HIV dementia. Cell Death Differ. 2005, 12(Suppl. 1):893-904.
37. McArthur J., Smith B. Neurologic complications and considerations in HIV-infected persons. Curr. Infect. Dis. Rep. 2013, 15:61-66.
38. Meisel A., Harms C., Yildirim F., Bosel J., Kronenberg G., Harms U., Fink K.B., Endres M. Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation. J. Neurochem. 2006, 98:1019-1031.
39. Meucci O., Miller R.J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J. Neurosci. 1996, 16:4080-4088.
40. Misonou H., Mohapatra D.P., Park E.W., Leung V., Zhen D., Misonou K., Anderson A.E., Trimmer J.S. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat. Neurosci. 2004, 7:711-718.
41. Montalbetti N., Li Q., Timpanaro G.A., Gonzalez-Perrett S., Dai X.Q., Chen X.Z., Cantiello H.F. Cytoskeletal regulation of calcium-permeable cation channels in the human syncytiotrophoblast: role of gelsolin. J. Physiol. 2005, 566:309-325.
42. Mothobi N.Z., Brew B.J. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr. Opin. Infect. Dis. 2012, 25:4-9.
43. Muller W.E., Schroder H.C., Ushijima H., Dapper J., Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmacol. 1992, 226:209-214.
44. + current in rat hippocampal neurons. J. Neurosci. 1999, 19:1728-1735.
45. Nath A., Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 1998, 54:19-33.
46. Nath A., Haughey N.J., Jones M., Anderson C., Bell J.E., Geiger J.D. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 2000, 47:186-194.
47. Pal S., Hartnett K.A., Nerbonne J.M., Levitan E.S., Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J. Neurosci. 2003, 23:4798-4802.
48. + channels. Cell Death Differ. 2006, 13:661-667.
49. Pannaccione A., Boscia F., Scorziello A., Adornetto A., Castaldo P., Sirabella R., Taglialatela M., Di Renzo G.F., Annunziato L. Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death. Mol. Pharmacol. 2007, 72:665-673.
50. Peng X., Zhang X., Wang L., Zhu Q., Luo J., Wang W., Wang X. Gelsolin in cerebrospinal fluid as a potential biomarker of epilepsy. Neurochem. Res. 2011, 36:2250-2258.
51. Pieri M., Amadoro G., Carunchio I., Ciotti M.T., Quaresima S., Florenzano F., Calissano P., Possenti R., Zona C., Severini C. SP protects cerebellar granule cells against beta-amyloid-induced apoptosis by down-regulation and reduced activity of Kv4 potassium channels. Neuropharmacology 2010, 58:268-276.
52. Potter M.C., Figuera-Losada M., Rojas C., Slusher B.S. Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J. NeuroImmune Pharmacol. 2013, 8:594-607.
53. Pottiez G., Haverland N., Ciborowski P. Mass spectrometric characterization of gelsolin isoforms. Rapid Commun. Mass Spectrom. 2010, 24:2620-2624.
54. Qiao H., McMillan J.R. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC. FEBS Lett. 2007, 581:535-540.
55. + channels: an essential pathway in programmed cell death. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L49-L67.
56. Rozek W., Ricardo-Dukelow M., Holloway S., Gendelman H.E., Wojna V., Melendez L.M., Ciborowski P. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J. Proteome Res. 2007, 6:4189-4199.
57. Schafer D.A., Cooper J.A. Control of actin assembly at filament ends. Annu. Rev. Cell Dev. Biol. 1995, 11:497-518.
58. Shen Q.J., Zhao Y.M., Cao D.X., Wang X.L. Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons. J. Neurosci. Res. 2009, 87:3153-3160.
59. Tun C., Guo W., Nguyen H., Yun B., Libby R.T., Morrison R.S., Garden G.A. Activation of the extrinsic caspase pathway in cultured cortical neurons requires p53-mediated down-regulation of the X-linked inhibitor of apoptosis protein to induce apoptosis. J. Neurochem. 2007, 102:1206-1219.
60. Wiederin J., Rozek W., Duan F., Ciborowski P. Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci. 2009, 7:8.
61. Wu P., Price P., Du B., Hatch W.C., Terwilliger E.F. Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. Neuroreport 1996, 7:1045-1049.
62. Xiong H., Zeng Y.C., Lewis T., Zheng J., Persidsky Y., Gendelman H.E. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J. Neurovirol. 2000, 6(Suppl. 1):S14-S23.
63. Yin H.L., Kwiatkowski D.J., Mole J.E., Cole F.S. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J. Biol. Chem. 1984, 259:5271-5276.
64. Yu S.P. Regulation and critical role of potassium homeostasis in apoptosis. Prog. Neurobiol. 2003, 70:363-386.
65. Yu S.P., Yeh C.H., Sensi S.L., Gwag B.J., Canzoniero L.M., Farhangrazi Z.S., Ying H.S., Tian M., Dugan L.L., Choi D.W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997, 278:114-117.
66. Zhang Q.H., Chen Q., Kang J.R., Liu C., Dong N., Zhu X.M., Sheng Z.Y., Yao Y.M. Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury. J. Neuroinflammation 2011, 8:118.